Related Experiment Video
Updated: Jul 11, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C virus in infants and children
1University of California, San Francisco 94143-0136, USA.
Current Opinion in Pediatrics
|November 14, 1997
Summary
Hepatitis C virus (HCV) infection in children is increasingly studied, with rapid advances in understanding its spread, effects, and treatment. New research offers better diagnosis and care for pediatric HCV patients.
Area of Science:
- Pediatric Infectious Diseases
- Hepatology
- Virology
Background:
- Hepatitis C virus (HCV) affects about 1% of the global population.
- Pediatric HCV infection historically received limited research attention.
- Recent data on pediatric HCV epidemiology, clinical presentation, genotypes, and evolution are rapidly emerging.
Purpose of the Study:
- To summarize recent advancements in the diagnosis, epidemiology, natural history, and therapy of HCV in children.
- To discuss the implications of these advances for pediatric and primary care.
Main Methods:
- Review of current literature on pediatric Hepatitis C virus infection.
- Analysis of data from multicenter and multinational clinical protocols and therapeutic trials involving children.
- Synthesis of information on diagnosis, epidemiology, natural history, and treatment.
Main Results:
- Significant accumulation of new data on pediatric HCV infection.
- Growing number of children participating in clinical studies and trials.
- Advances in understanding the spectrum of HCV in children.
Conclusions:
- Recent progress necessitates updates in clinical practice for pediatric HCV.
- Pediatric and primary care providers need to be aware of current diagnostic and therapeutic strategies.
- Continued research is crucial for managing childhood HCV effectively.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...